Immunochromatographic test for the detection of SARS-CoV-2 in saliva.


Journal

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
ISSN: 1437-7780
Titre abrégé: J Infect Chemother
Pays: Netherlands
ID NLM: 9608375

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 28 08 2020
revised: 06 11 2020
accepted: 11 11 2020
pubmed: 6 1 2021
medline: 30 1 2021
entrez: 5 1 2021
Statut: ppublish

Résumé

We evaluated the rapid immunochromatographic test for severe acute respiratory coronavirus 2 (SARS-CoV-2) antigen detection using 16 saliva specimens collected from 6 COVID-19 hospitalized patients, and detected N-antigen in 4 of 7 RT-PCR positive specimens. This POCT detected SARS-CoV-2 antigen in saliva and would be useful for COVID-19 diagnosis.

Identifiants

pubmed: 33397587
pii: S1341-321X(20)30423-2
doi: 10.1016/j.jiac.2020.11.016
pmc: PMC7755575
pii:
doi:

Substances chimiques

Antigens, Viral 0
RNA, Viral 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

384-386

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest SY is an employee and KaA is the director of Fujirebio Inc.

Références

Jpn J Infect Dis. 2020 Jul 22;73(4):304-307
pubmed: 32074516
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32317257
Clin Microbiol Infect. 2021 Feb;27(2):285.e1-285.e4
pubmed: 32422408
Int J Oral Sci. 2020 Apr 17;12(1):11
pubmed: 32300101
Lancet Infect Dis. 2020 May;20(5):565-574
pubmed: 32213337
Clin Infect Dis. 2020 Jul 28;71(15):841-843
pubmed: 32047895
Cell Prolif. 2020 Dec;53(12):e12923
pubmed: 33073910

Auteurs

Katsuhito Kashiwagi (K)

General Medicine and Emergency Center (Internal Medicine), Toho University Omori Medical Center, 6-11-1 Omori-nishi, Ota-ku, 1438541, Tokyo, Japan.

Yoshikazu Ishii (Y)

Department of Microbiology and Infectious Diseases, Toho University School of Medicine, 5-21-16 Omori-nishi, Ota-ku, 1438540, Tokyo, Japan.

Kotaro Aoki (K)

Department of Microbiology and Infectious Diseases, Toho University School of Medicine, 5-21-16 Omori-nishi, Ota-ku, 1438540, Tokyo, Japan.

Shintaro Yagi (S)

Fujirebio Inc., 51 Komiya-machi, Hachioji, 192-0031, Tokyo, Japan. Electronic address: shintaro.yagi@hugp.com.

Tadashi Maeda (T)

General Medicine and Emergency Center (Internal Medicine), Toho University Omori Medical Center, 6-11-1 Omori-nishi, Ota-ku, 1438541, Tokyo, Japan.

Taito Miyazaki (T)

General Medicine and Emergency Center (Internal Medicine), Toho University Omori Medical Center, 6-11-1 Omori-nishi, Ota-ku, 1438541, Tokyo, Japan.

Sadako Yoshizawa (S)

General Medicine and Emergency Center (Internal Medicine), Toho University Omori Medical Center, 6-11-1 Omori-nishi, Ota-ku, 1438541, Tokyo, Japan; Department of Microbiology and Infectious Diseases, Toho University School of Medicine, 5-21-16 Omori-nishi, Ota-ku, 1438540, Tokyo, Japan.

Katsumi Aoyagi (K)

Fujirebio Inc., 51 Komiya-machi, Hachioji, 192-0031, Tokyo, Japan.

Kazuhiro Tateda (K)

Department of Microbiology and Infectious Diseases, Toho University School of Medicine, 5-21-16 Omori-nishi, Ota-ku, 1438540, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH